Synthetic peptides produced by solid-phase peptide synthesis (SPPS) are not pure immediately after synthesis. Crude peptides contain deletion sequences, truncated chains, protecting-group residues, and synthesis byproducts. Preparative high-performance liquid chromatography (prep-HPLC) is the gold-standard method for isolating pure peptide from the crude mixture. This guide explains the method, optimization strategies, and scale-up from analytical to preparative scales.
Crude peptides from SPPS are typically 30–60% the desired sequence; the remainder is a complex mixture of deletion sequences (missing one or more amino acids), truncated chains (incomplete synthesis), and synthesis byproducts. Even minor impurities can alter biological activity and compromise reproducibility in downstream applications. Preparative HPLC physically separates peptides by hydrophobicity, allowing isolation of the target sequence in high purity (typically 95–99%).
Reversed-phase liquid chromatography (RPLC) using C4, C8, or C18 stationary phases remains the most widely applied technique for peptide purification. The principle: peptides are injected into a column packed with non-polar (hydrophobic) material, then eluted with increasing concentrations of organic solvent (acetonitrile). Peptides that are more hydrophobic elute later; less hydrophobic peptides elute earlier. This separation strategy works for most peptides and is robust across scales.
Trifluoroacetic acid (TFA): Traditionally used as the mobile-phase modifier. TFA improves peptide resolution and ensures strong ion suppression, enhancing separation. However, TFA has drawbacks: it is difficult to remove from purified peptide (requires extensive evaporation), and it can interfere with downstream applications (mass spectrometry, certain biological assays).
Formic acid (FA): A gentler alternative that improves peptide ionization and is easier to remove post-purification. Recent 2026 research documented that switching from TFA to FA significantly improved separation for certain peptide classes, particularly those with polar residues or charge heterogeneity. The choice depends on your peptide sequence and downstream applications.
Step 1: Develop an analytical method. Begin with analytical HPLC (3–4.6 mm column, 1 mL/min flow rate) to establish a robust separation. The analytical method should achieve complete resolution between the desired peptide and the major impurities.
Step 2: Optimize chromatographic parameters. Key parameters affecting separation:
Step 3: Scale the column. For preparative purification, column inner diameter increases from analytical (4.6 mm) to 10–50 mm depending on batch size. Flow rate scales proportionally with column cross-sectional area (for a 10 mm column, flow rate is roughly (10/4.6)² times the analytical flow rate).
Step 4: Method transfer and validation. After scaling, run test injections on the preparative column to confirm that separation is maintained. Make minor adjustments to gradient if needed. Once optimized, the method should be reproducible across multiple purification runs.
1. Crude peptide preparation: Dissolve crude peptide in solvent (typically aqueous TFA or acetonitrile/water) at a concentration that does not overload the column.
2. Injection and elution: Inject the crude peptide sample onto the prep-HPLC column. Collect fractions corresponding to the elution time of the desired peptide (identified from analytical HPLC).
3. Post-purification workup: Combine collected fractions, evaporate solvent under reduced pressure, and re-evaporate with water to remove residual TFA (if using TFA). Lyophilize or air-dry to yield the pure peptide.
4. Quality control: Analyze the purified peptide by analytical HPLC (purity %), mass spectrometry (molecular weight), and amino acid analysis (composition) to confirm identity and purity.
After purification, analytical HPLC provides an accurate purity percentage (area % of the desired peak vs. total peak area). A well-purified peptide typically shows 95–99% purity, with the remainder being failure sequences or minor synthetic byproducts. If purity is below 95%, re-purification on a different gradient or column may be necessary.
We supply peptides that have undergone rigorous preparative HPLC purification and analytical validation. Every batch is ≥98% pure (confirmed by HPLC), with certificate of analysis including chromatogram and molecular weight verification. This eliminates the need for in-house purification and guarantees you receive a pure, defined compound.
Browse purified research peptides
Universe Peptide publishes research-focused education for the scientific community. Products are for laboratory research only. See more in our News & research updates.